Related Experiment Videos
IgG subclass deficiency in children with recurrent infections
1Immunology Unit, Hacettepe University Institute of Child Health, Ankara.
The Turkish Journal of Pediatrics
|July 1, 1991
Summary
In children with recurrent respiratory infections, IgG subclass deficiency was identified in 16.6%. Early consideration of IgG subclass deficiency is crucial, even with normal immunoglobulin levels, for effective treatment.
Area of Science:
- Pediatric Immunology
- Infectious Diseases
Background:
- Recurrent respiratory tract infections (RRTIs) in children can stem from various causes.
- While low immunoglobulin levels are a known factor, IgG subclass deficiencies may also contribute.
- IgA deficiency and generalized hypogammaglobulinemia were excluded in this cohort.
Purpose of the Study:
- To investigate IgG subclass levels in children experiencing recurrent respiratory tract infections.
- To determine the prevalence of IgG subclass deficiencies in this pediatric population.
- To assess the clinical implications and treatment response in affected children.
Main Methods:
- Analysis of IgG subclass levels (IgG1, IgG2, IgG3, IgG4) in 12 children (aged 2.5-12 years) with RRTIs.
- Clinical evaluation including assessment for bronchiectasis and history of severe pneumonia.
- Treatment response to prophylactic antibiotics and subsequent gammaglobulin therapy was monitored.
Main Results:
- A combined deficiency of IgG2 and IgG4 was found in one patient.
- Selective IgG2 deficiency was identified in another patient, resulting in a 16.6% prevalence of IgG subclass deficiency.
- Two patients with IgG subclass deficiency developed bronchiectasis secondary to severe pneumonia; however, one bronchiectasis patient had normal IgG subclass levels.
Conclusions:
- IgG subclass deficiency, particularly IgG2 deficiency, should be considered in children with unexplained recurrent infections.
- Normal serum immunoglobulin levels do not exclude the possibility of underlying IgG subclass deficiency.
- Gammaglobulin therapy may be beneficial for IgG subclass-deficient patients unresponsive to antibiotics.